Affinity DataIC50: 130nMAssay Description:Inhibition of fibrinogen binding to rat platelet integrin alpha2b beta3 by ELISA based solid phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 136nMAssay Description:Inhibition of fibrinogen binding to rat platelet integrin alpha2b beta3 by ELISA based solid phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 603nMAssay Description:Inhibition of fibrinogen binding to rat platelet integrin alpha2b beta3 by ELISA based solid phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 610nMAssay Description:Inhibition of fibrinogen binding to rat platelet integrin alpha2b beta3 by ELISA based solid phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 890nMAssay Description:Inhibition of fibrinogen binding to rat platelet integrin alpha2b beta3 by ELISA based solid phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 897nMAssay Description:Inhibition of fibrinogen binding to rat platelet integrin alpha2b beta3 by ELISA based solid phase binding assayMore data for this Ligand-Target Pair
TargetIntegrin beta-3/subunit alpha 2b(Rattus norvegicus)
Capital Medical University
Curated by ChEMBL
Capital Medical University
Curated by ChEMBL
Affinity DataEC50: 1.66E+3nMAssay Description:Binding affinity to GP2b/3a in rat blood assessed as conformational change by measuring soluble GP2b/3a levels after 12 hrs by UV-spectrophotometric ...More data for this Ligand-Target Pair
Affinity DataEC50: 1.16E+3nMAssay Description:Binding affinity to GP2b/3a in rat blood assessed as conformational change by measuring soluble GP2b/3a levels after 12 hrs by UV-spectrophotometric ...More data for this Ligand-Target Pair